Where biotin is permitted, and what the file must show
D-biotin is permitted in EU and UK food supplements and is a lawful dietary ingredient in the US, but permission is only the first check. The form, the contaminant ceiling, the nutrition declaration and the claim wording each need their own evidence, and the file has to answer all four for the destination market.
Permitted is not the same as compliant: the form, the contaminant ceiling, the label and the claim each need their own evidence.
Three markets, four questions
The EU regulates food supplements through Directive 2002/46/EC, which sets a positive list of vitamins and of the forms that may be used. The US regulates biotin as a dietary ingredient under the Federal Food, Drug, and Cosmetic Act as amended by DSHEA, with cGMP in 21 CFR 111 and the Supplement Facts panel in 21 CFR 101.36. The UK applies assimilated food supplement and labelling rules, with retained nutrition and claims references.
In all three, the same four questions apply: is the exact form permitted, does the finished product meet the contaminant limits, does the label declare the nutrient in the right unit against the right reference value, and is the claim one that may be used for this product?
The EU source list and the label
Biotin appears in Annex II, Part A, entry 12(a) of Directive 2002/46/EC as D-biotin, and that is the form the file has to name. The Annex is amended by Commission regulation, so the entry should be checked against the current consolidated text as of this review.
The nutrition declaration gives biotin in micrograms with the percentage of the nutrient reference value, 50 µg under Regulation (EU) No 1169/2011; a 100 µg portion is 200% of the NRV. The EU has not harmonised maximum levels for vitamins in supplements, and several member states set their own, so a multi-market product is checked market by market. The supplement particulars cover the food supplement name, the amount per portion, the NRV percentage, the daily-dose and keep-out-of-reach warnings and the varied-diet statement; the operator placing the product on the market carries the label responsibility.
The US route is a different route
Biotin is a lawful dietary ingredient. Biotin has been marketed as a dietary ingredient since before 1994 and is treated as a pre-DSHEA ingredient, so the NDI notification route does not apply; the manufacturer still has to meet 21 CFR 111 and the Supplement Facts rules. The daily value is 30 µg for adults and children four years and older, so a 100 µg serving is 333% of the daily value.
The Institute of Medicine did not set a tolerable upper intake level for biotin in 1998, which is a statement about the evidence, not a licence to formulate without a limit. There is also no federal maximum level for lead, cadmium, mercury or arsenic in supplements. The cGMP rule still requires manufacture to specification, California Proposition 65 sets a lead dose level of 0.5 µg per day with a warning above it, and the calculation is on daily intake, not drum concentration.
Contaminants and the specification
| Contaminant | EU | US |
|---|---|---|
| Lead | 3.0 mg/kg in food supplements | No federal limit; California Prop 65 applies |
| Cadmium | 1.0 mg/kg in food supplements | No federal limit for supplements |
| Mercury | 0.10 mg/kg in food supplements | No federal limit for supplements |
| Arsenic | No harmonised EU limit; national rules may apply | No federal limit for supplements |
The EU limits sit in Regulation (EU) 2023/915; the UK applies assimilated contaminants rules, and the current GB text should be checked. The catalog specification sets Pb ≤3, As ≤2, Cd ≤1 and Hg ≤0.1 mg/kg: it meets the EU lead, cadmium and mercury limits and sets an arsenic figure where the EU has none. That specification is a buyer's choice, not a legal requirement. The micro limits, APC ≤1,000 cfu/g, yeast and mould ≤100 cfu/g and absence of E. coli and Salmonella, are also specification lines, and the certificate should name the method and the test portion.
Where the claim boundary sits
In the EU and the UK, only claims on the authorised register may be used, and each entry carries conditions of use. Biotin appears in the register, but the wording is not interchangeable with a paraphrase: the register text is the claim. The source-of threshold for a vitamin is 15% of the NRV in the daily portion, which is 7.5 µg of biotin against the 50 µg NRV.
In the US, structure/function claims are permitted with the DSHEA disclaimer and the notification where it applies; disease claims are not. Nothing on this page is a claim about the ingredient, and a bulk technical document is safest when it makes no health claim at all. The buyer's label is where a permitted claim belongs.
The file that travels with the lot
| Document | What it has to show |
|---|---|
| Certificate of analysis | Lot, methods, limits, results and assay basis; rotation and LOD beside the assay |
| Specification and TDS | Grade, carrier, particle size, pack, storage and retest |
| SDS | Dust, moisture and handling precautions in the current format |
| Contaminant and micro statements | ICP-MS and plate counts, with methods and test portions |
| Allergen, GMO and irradiation statements | Declarations for the regulated allergens and process treatments |
| Origin and flow chart | Manufacturing site, carrier source and the steps that affect moisture |
| Food-contact declaration | The pouch, liner and drum are declared for the destination market |
| Stability summary | The pack, conditions and retest period behind the certificate date |
One line is easy to miss: biotin can interfere with immunoassays that use the biotin–streptavidin system. The US FDA issued a safety communication in 2017 and updated it in 2019; the effect depends on the sample concentration and the assay design and can push a result in either direction. The supplier's file should state the biotin content per portion and identify milligram-level formats, so the brand can decide on label and laboratory communication. That is a method and label fact, not a claim about the ingredient.
Before the pack ships
- The label name matches D-biotin in Annex II, the US dietary ingredient route and the UK list.
- The nutrition declaration uses micrograms and the right reference value: 50 µg in the EU and UK, 30 µg in the US.
- The dose has been checked against any national maximum and the product's own formulation limit.
- The contaminant results meet the destination limit, with method and test portion named.
- The carrier is declared and the grade is not described as pure material.
- The claim text, if any, comes from the register or the notification with its condition of use.
- The storage statement matches the pack and the stability summary.
- The biotin-per-portion statement is in the file for the immunoassay communication.
The market notes are on the EU, US and UK regulatory pages. The catalog specification is on the biotin product page, the certificate lines on the COA page and the identity tests on the identity page.
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation